Kushner, R. F., Garvey, W. T., Hesse, D., Koroleva, A., Lim, S., Lingvay, I., . . . le Roux, C. W. (2021). Once-weekly Subcutaneous Semaglutide 2.4 mg Reduces Body Weight in Adults with Overweight or Obesity Regardless of Baseline Characteristics (STEP 1). J Endocr Soc.
Citación estilo ChicagoKushner, Robert F., et al. "Once-weekly Subcutaneous Semaglutide 2.4 Mg Reduces Body Weight in Adults With Overweight or Obesity Regardless of Baseline Characteristics (STEP 1)." J Endocr Soc 2021.
Cita MLAKushner, Robert F., et al. "Once-weekly Subcutaneous Semaglutide 2.4 Mg Reduces Body Weight in Adults With Overweight or Obesity Regardless of Baseline Characteristics (STEP 1)." J Endocr Soc 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.